Aarti Drugs share news, announcements and annual reports
NSE: AARTIDRUGSBSE: 524348Pharmaceuticals & BiotechnologySmall Cap
Aarti Drugs Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Sep 1993 on BSE, Sep 2003 on NSE
Last close ₹435.20down ₹13.80 (3.07%)BSE ₹435.70
Share price at the NSE close on 30 Oct 2026. Previous close ₹449.00.
30 Oct: open ₹444.00, high ₹449.00, low ₹432.50
52-week range of traded prices to 30 Oct 2026
₹318.95Low, 30 Mar 2026₹534.00High, 10 Nov 2025
- Next results date: the board meets on 3 Nov 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹3,972 Cr930th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.78
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 2.56
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.46%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.1%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 12.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.37
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,91,56330.3% delivered
Aarti Drugs has 832 announcements on record, routine notices left out; 3 in the 30 days to 2 Nov 2026, the latest on 28 Oct 2026.
Next board meeting and results date
As the company gave notice to the exchange.Aarti Drugs quarterly results
Nov3Tue
The board meets on 3 Nov 2026 to consider financial results
Notice filed 27 Oct 2026
To consider and approve the financial results for the period ended September 30, 2026
Aarti Drugs annual reports, presentations and earnings calls
The company's own documents, latest first.Aarti Drugs financials, year by year
Annual reports17
- Annual report, year to Mar 20262 Sep 2026
- Annual report, year to Mar 202530 Aug 2025
- Annual report, year to Mar 202429 Aug 2024
- Annual report, year to Mar 20232 Sep 2023, a zip file
- Annual report, year to Mar 202211 Jul 2022, a zip file
12 earlier reports
- Annual report, year to Mar 202111 Aug 2021, a zip file
- Annual report, year to Mar 202031 Jul 2020, a zip file
- Annual report, year to Mar 201911 Jul 2019, a zip file
- Annual report, year to Mar 201816 Aug 2018, a zip file
- Annual report, year to Mar 201731 Aug 2017, a zip file
- Annual report, year to Mar 201615 Sep 2016, a zip file
- Annual report, year to Mar 201517 Jul 2015, a zip file
- Annual report, year to Mar 201417 Jun 2014, a zip file
- Annual report, year to Mar 20129 Jul 2013, a zip file
- Annual report, year to Mar 20139 Jul 2013, a zip file
- Annual report, year to Mar 201121 Jul 2011, a zip file
- Annual report, year to Mar 201018 Aug 2010, a zip file
Investor presentations35
- Presentation made to the shareholders at 41st Annual General Meeting26 Sep 2026
- Investor Presentation1 Aug 2026
- Investor Presentation16 May 2026
- Investor Presentation3 Feb 2026
- Investor Presentation7 Nov 2025
30 earlier presentations
- Presentation made to the shareholders at 40th AGM24 Sep 2025
- Investor Presentation19 Jul 2025
- Investor Presentation6 May 2025
- Investor Presentation29 Jan 2025
- Q2 and H1 FY25 Investor Presentation24 Oct 2024
- Investor Presentation20 Sep 2024
- Investor Presentation26 Jul 2024
- Investor Presentation4 May 2024
- Investor Presentation24 Jan 2024
- Investor Presentation19 Oct 2023
- Investor Presentation26 Sep 2023
- Investor Presentation21 Jul 2023
- Investor Presentation2 May 2023
- Investor Presentation27 Jan 2023
- Investor Presentation20 Oct 2022
- Investor Presentation4 Aug 2022
- Investor Presentation27 Jul 2022
- Revised Q4FY22 Results Presentation7 Jun 2022
- Investor Presentation9 May 2022
- Investor Presentation31 Jan 2022
- Investor Presentation27 Oct 2021
- Investor Presentation28 Jul 2021
- Investor Presentation17 May 2021
- Investor Presentation for Q3FY21 Results28 Jan 2021
- Investor Presentation on Q2FY21 Results2 Nov 2020
- Investor Presentation17 Aug 2020
- Investor Presentation23 Jun 2020
- Investor Presentation29 May 2019
- Corporate Presentation Feb, 2016 (update)16 Feb 2016, a zip file
- Corporate Presentation.29 Dec 2015, a zip file
Earnings calls40
- Transcript7 Aug 2026
- Link of Recording3 Aug 2026
- Transcript23 May 2026
- Link of Recording18 May 2026
- Transcript10 Feb 2026
35 earlier call documents
- Link of Recording4 Feb 2026
- Transcript14 Nov 2025
- Link of Recording10 Nov 2025
- Transcript25 Jul 2025
- Link of Recording21 Jul 2025
- Transcript12 May 2025
- Link of Recording7 May 2025
- Transcript4 Feb 2025
- Link of Recording30 Jan 2025
- Transcript2 Nov 2024
- Link of Recording25 Oct 2024
- Transcript5 Aug 2024
- Link of Recording29 Jul 2024
- Transcript10 May 2024
- Link of Recording6 May 2024
- Transcript1 Feb 2024
- Link of Recording25 Jan 2024
- Transcript27 Oct 2023
- Link of Recording20 Oct 2023
- Transcript28 Jul 2023
- Link of Recording24 Jul 2023
- Transcript7 May 2023
- Link of Recording2 May 2023
- Transcript3 Feb 2023
- Link of Recording30 Jan 2023
- Transcript of Analysts/Institutional Investor Meet/Con. Call31 Oct 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call21 Oct 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call3 Aug 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call28 Jul 2022
- Transcript of Analysts/Institutional Investor Meet/Con. Call16 May 2022
- Recording of Analysts/Institutional Investor Meet/Con. Call10 May 2022
- Transcript14 Feb 2022
- Transcript15 Nov 2021
- Transcript of Q1 FY2022 Earning Conference Call31 Aug 2021
- Transcript of Q4 FY2021 Earning Conference Call9 Jun 2021
Aarti Drugs share news and announcements
Newest first. Page 1 of 17.
Oct 2026
28 Oct · Analysts
27 Oct · Board meeting
8 Oct · General Updates
1 Oct
Sep 2026
30 Sep · Management
30 Sep · Management
26 Sep · Management
26 Sep · Updates
26 Sep · Meeting
Aug 2026
27 Aug · Board meeting
24 Aug · Board meeting
14 Aug · Analysts
4 Aug · Analysts
1 Aug · Legal
Jul 2026
31 Jul · Board meeting
31 Jul · Results
29 Jul · Analysts
24 Jul · Board meeting
18 Jul · Legal
Jun 2026
16 Jun · Analysts
5 Jun · Analysts
May 2026
22 May · Analysts
15 May · Results
12 May · Analysts
8 May · Board meeting
Apr 2026
Mar 2026
24 Mar · Rating
7 Mar
4 Mar · Analysts
2 Mar
Feb 2026
4 Feb · Analysts
3 Feb · Corporate action
3 Feb · Results
Jan 2026
29 Jan · Rating
28 Jan · Analysts
Nov 2025
7 Nov · Results
How the price met the news
The latest 30. The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.Delivery against usualDelivery against usual. The share of the session's volume delivered into demat accounts, rather than bought and sold again the same day, less its average over the twenty sessions before, in percentage points (pts). Delivery against usual in the glossary
- 1 Oct 2026Board or managers changeddown 2.30%−1.3 pts vs Nifty 500market median 0.0% · five sessions −3.9% (−1.9 pts vs Nifty 500) · volume 0.8× usual · delivery −0.2 pts against usual · The announcement
- 18 May 2026Resultsdown 0.50%−0.2 pts vs Nifty 500market median −0.7% · five sessions +6.0% (+5.5 pts vs Nifty 500) · volume 0.9× usual · delivery −0.5 pts against usual · The announcement
- 25 Mar 2026Credit ratingup 1.68%−0.3 pts vs Nifty 500market median 0.0% · five sessions +5.1% (+5.8 pts vs Nifty 500) · volume 1.0× usual · delivery −1.0 pts against usual · The announcement
- 30 Jan 2026Credit ratingup 1.63%+1.9 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−2.8 pts vs Nifty 500) · volume 0.7× usual · delivery −9.8 pts against usual · The announcement
- 7 Nov 2025Resultsup 0.52%+0.5 pts vs Nifty 500market median −0.7% · five sessions −4.0% (−5.3 pts vs Nifty 500) · volume 3.0× usual · delivery −26.1 pts against usual · The announcement
- 25 Sep 2025Board or managers changeddown 1.95%−1.3 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−4.6 pts vs Nifty 500) · volume 0.9× usual · delivery −0.6 pts against usual · The announcement
- 21 Jul 2025Resultsup 4.18%+3.7 pts vs Nifty 500market median −0.7% · five sessions +2.8% (+3.9 pts vs Nifty 500) · volume 3.8× usual · delivery −18.4 pts against usual · The announcement
- 7 May 2025Resultsup 19.99%+19.5 pts vs Nifty 500market median −0.7% · five sessions +29.6% (+27.8 pts vs Nifty 500) · volume 42.8× usual · delivery −30.8 pts against usual · The announcement
- 31 Jan 2025Credit ratingdown 0.63%−2.0 pts vs Nifty 500market median 0.0% · five sessions +1.9% (−0.4 pts vs Nifty 500) · volume 0.6× usual · delivery −1.9 pts against usual · The announcement
- 30 Jan 2025Dividendup 2.84%+2.6 pts vs Nifty 500market median 0.0% · five sessions +4.4% (+2.2 pts vs Nifty 500) · volume 1.9× usual · delivery −25.3 pts against usual · The announcement
20 earlier announcements
- 31 Oct 2024Credit ratingdown 0.11%+0.2 pts vs Nifty 500market median 0.0% · five sessions +2.0% (+0.7 pts vs Nifty 500) · volume 0.9× usual · delivery −3.5 pts against usual · The announcement
- 30 Sep 2024Buybackdown 0.22%+0.8 pts vs Nifty 500market median 0.0% · five sessions −1.0% (+4.4 pts vs Nifty 500) · volume 0.8× usual · delivery −3.6 pts against usual · The announcement
- 10 Sep 2024Buybackdown 0.95%−1.6 pts vs Nifty 500market median 0.0% · five sessions −2.7% (−4.7 pts vs Nifty 500) · volume 0.4× usual · delivery −3.9 pts against usual · The announcement
- 29 Aug 2024Buybackdown 0.02%−0.1 pts vs Nifty 500market median 0.0% · five sessions −1.7% (−2.2 pts vs Nifty 500) · volume 0.9× usual · delivery −6.5 pts against usual · The announcement
- 29 Jul 2024Resultsdown 4.45%−4.9 pts vs Nifty 500market median −0.7% · five sessions −2.9% (−2.8 pts vs Nifty 500) · volume 1.9× usual · delivery +4.8 pts against usual · The announcement
- 1 Mar 2024Credit ratingup 1.05%−0.2 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−4.7 pts vs Nifty 500) · volume 0.7× usual · delivery −10.5 pts against usual · The announcement
- 25 Jan 2024Dividenddown 5.74%−5.4 pts vs Nifty 500market median 0.0% · five sessions −1.5% (−3.2 pts vs Nifty 500) · volume 2.1× usual · delivery −5.6 pts against usual · The announcement
- 18 Sep 2023Credit ratingup 1.53%+1.8 pts vs Nifty 500market median 0.0% · five sessions −5.6% (−3.4 pts vs Nifty 500) · volume 0.5× usual · delivery −3.3 pts against usual · The announcement
- 4 Sep 2023Buybackup 4.27%+3.6 pts vs Nifty 500market median 0.0% · five sessions +8.8% (+6.4 pts vs Nifty 500) · volume 2.3× usual · delivery +12.6 pts against usual · The announcement
- 28 Aug 2023Buybackdown 1.15%−1.5 pts vs Nifty 500market median 0.0% · five sessions +5.8% (+4.3 pts vs Nifty 500) · volume 0.7× usual · delivery +1.7 pts against usual · The announcement
- 8 Aug 2023Buybackup 3.01%+3.1 pts vs Nifty 500market median 0.0% · five sessions +0.4% (+1.1 pts vs Nifty 500) · volume 0.2× usual · delivery −0.2 pts against usual · The announcement
- 26 Jul 2023Buybackdown 4.45%−4.9 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−2.8 pts vs Nifty 500) · volume 1.6× usual · delivery −13.5 pts against usual · The announcement
- 24 Jul 2023Buybackup 18.60%+18.8 pts vs Nifty 500market median 0.0% · five sessions +14.7% (+14.4 pts vs Nifty 500) · volume 25.8× usual · delivery −28.9 pts against usual · The announcement
- 30 Jan 2023Dividenddown 1.62%−1.5 pts vs Nifty 500market median 0.0% · five sessions +2.2% (+1.6 pts vs Nifty 500) · volume 5.2× usual · delivery −34.4 pts against usual · The announcement
- 31 Jan 2022Dividendup 1.18%−0.2 pts vs Nifty 500market median 0.0% · five sessions +5.5% (+3.1 pts vs Nifty 500) · volume 2.2× usual · delivery −17.2 pts against usual · The announcement
- 27 May 2021Buybackup 0.34%0.0 pts vs Nifty 500market median 0.0% · five sessions +4.6% (+2.6 pts vs Nifty 500) · volume 0.3× usual · delivery +1.3 pts against usual · The announcement
- 21 May 2021Buybackdown 0.95%−2.4 pts vs Nifty 500market median 0.0% · five sessions −3.4% (−6.0 pts vs Nifty 500) · volume 0.4× usual · delivery +13.8 pts against usual · The announcement
- 4 May 2021Credit ratingdown 1.15%−0.4 pts vs Nifty 500market median 0.0% · five sessions +13.1% (+10.9 pts vs Nifty 500) · volume 0.5× usual · delivery +5.0 pts against usual · The announcement
- 16 Apr 2021Credit ratingdown 0.28%−0.8 pts vs Nifty 500market median 0.0% · five sessions +1.6% (+2.7 pts vs Nifty 500) · volume 0.2× usual · delivery +1.8 pts against usual · The announcement
- 30 Mar 2021Credit ratingdown 0.88%−2.8 pts vs Nifty 500market median 0.0% · five sessions −2.5% (−4.3 pts vs Nifty 500) · volume 0.4× usual · delivery +0.1 pts against usual · The announcement
Aarti Drugs results filing dates and deadlines
Listed companies must file quarterly results within 45 days, and the year's within 60.
Days to fileDays to file. The days from the period's end to the day the results reached the exchange.DeadlineDeadline, days. The days the rules allow from the period's end: 45 for a quarter or half year, and 60 for the year and the March quarter filed with it. A company that listed after the period ended has until 21 days after its listing where that is later.